SPMS- Disease Overview, Epidemiology and Drug Overview
Report gives the overview of Secondary progressive multiple sclerosis disease indication in detail, highlights the SPMS epidemiology in the present scenario and in future (forecasted) as well in the key geographies across the globe and elaborates on the drugs prescribed and expected to be prescribed in SPMS by the physicians.
Multiple Sclerosis Definition
Types of MS
SPMS definition
Causes of SPMS
Profile of SPMS patient
Symptoms of SPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for SPMS
Types of MS
SPMS definition
Causes of SPMS
Profile of SPMS patient
Symptoms of SPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for SPMS
More Publications
Rhinitis: Market Intelligence Review and Insights
US$ 2,500.00
March 2018
50 pages
Parkinson's: Epidemiology Overview and Insights
US$ 2,000.00
March 2018
50 pages
Parkinson's: Pipeline Assessment and Insights
US$ 2,000.00
March 2018
100 pages
Cystic Fibrosis: Pipeline Assessment and Insights
US$ 2,000.00
March 2018
100 pages
Schizophrenia: Epidemiology Overview and Insights
US$ 2,000.00
March 2018
50 pages
